Zydus receives final approval from the USFDA for Clozapine Tablets USP

Mumbai, Dec 08: Pharma Major, Cadila Healthcare Ltd said that it US subsidiary Zydus Pharmaceuticals (USA) Inc., has received the final approval from the USFDA to market Clozapine Tablets in strengths of 25 mg, 50 mg, 100 mg and 200 mg. 
The drug is used to treat schizophrenia. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad. The group now has more than 175 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04. UNI